Chronic somatostatin analog administration in patients with alpha-subunit-secreting pituitary tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 75, Issue 5, 1992, Pages 1318-1325

  Katznelson, Laurence ^a   Oppenheim, Daniel S ^a   Coughlin, John F ^a   Kliman, Bernard ^a   Schoenfeld, David A ^a   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOPHYSIS HORMONE; OCTREOTIDE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ALPHA CHAIN; ARTICLE; BETA CHAIN; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; GASTROINTESTINAL SYMPTOM; HORMONE INHIBITION; HORMONE RELEASE; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR CELL CULTURE; TUMOR VOLUME; VISUAL FIELD DEFECT;

ADENOMA; ADULT; AGED; FEMALE; GLYCOPROTEINS; HORMONES; HUMAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGE; OCTREOTIDE; PITUITARY NEOPLASMS; SOMATOSTATIN; SUPPORT, U.S. GOV'T, P.H.S.; VISUAL FIELDS;

EID: 0026440716     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.75.5.1358910     Document Type: Article

References (43)

1. Snyder PJ. 1985 Gonadotroph cell adenomas of the pituitary. Endocr Rev. 6:552-563.
2. Ridgway EC, Klibanski A, Ladenson PW, et al. 1981 Pure alpha-secreting pituitary adenomas. N Engl J Med. 304:1254-1259.
3. Kwekkeboom DJ, de Jong FH, Lamberts SWJ. 1989 Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropinreleasing hormone, gonadotropin-releasing hormone, and bromocriptine. J Clin Endocrinol Metab. 68:1128-1135.
4. Klibanski A, Shupnik MA, Bikkal HA, Black PM, Kliman B, Zervas NT. 1988 Dopaminergic regulation of a-subunit secretion and messenger ribonucleic acid levels in «-secreting pituitary tumors. J Clin Endocrinol Metab. 65:96-102.
5. Daneshdoost L, Gennarelli TA, Bashey HM, et al. 1991 Recognition of gonadotroph adenomas in women. N Engl J Med. 324:589-584.
6. Black PM, Hsu DW, Klibanski A, et al. 1987 Hormone production in clinically nonfunctioning pituitary adenomas. J Neurosurg. 66:244-250.
7. Jameson JL, Klibanski A, Black PM, et al. 1987 Glycoprotein hormone genes are expressed in clinically nonfunctioning adenomas. J Clin Invest. 80:1472-1478.
8. Katznelson L, Alexander JM, Bikkal HA, Jameson JL, Hsu DW, Klibanski A. 1992 Imbalanced follicle-stimulating hormone β-subunit hormone biosynthesis in human pituitary adenomas. J Clin Endocrinol Metab. 74:1343-51.
9. Oppenheim DS, Kana AR, Sangha JS, Klibanski A. 1990 Prevalence of a-subunit hypersecretion in patients with pituitary tumors: clinically nonfunctioning and somatotroph adenomas. J Clin Endocrinol Metab. 70:859-864.
10. Ishibashi M, Yamaji T, Takaku F, Teramoto A, Fukushima T. 1987 Secretion of glycoprotein hormone a-subunit by pituitary tumors. J Clin Endocrinol Metab. 64:1187-1193.
11. Harris RI, Schatz NJ, Gennarelli T, Savino PJ, Cobbs WH, Snyder PJ 1983 FSH secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery. J Clin Endocrinol Metab. 56:1288-1293.
12. MacFarlane IA, Beardwell CG, Shalet SM, Darbyshire PJ, Hayward E, Sutton ML. 1980 Glycoprotein hormone a-subunit secretion by pituitary adenomas: influence of external irradiation. Clin Endocrinol (Oxf). 13:215-222.
13. Ridgway EC, Klibanski A, Martorana MA, Milbury PE, Kieffer JD, Chin WW. 1983 The effect of somatostatin on TSH and subunit release in bovine anterior pituitary cells in vivo. Endocrinology. 112:1937-1942.
14. Beck-Peccoz P, Mariotti S, Guillausseau PJ, et al. 1989 Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995. J Clin Endocrinol Metab. 68:208-214.
15. Comi RJ, Gesundheit N, Murray L, Gorden P, Weintraub BD. 1987 Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N Engl J Med. 317:12-17.
16. Warnet A, Lajeunie E, Gelbert F, et al. 1991 Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995). Acta Endocinol (Copenh). 124:487-491.
17. Klibanski A, Alexander JM, Bikkal HA, Hsu DW, Swearingen B, Zervas NT. 1991 Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro. J Clin Endocrinol Metab. 73:1248-1255.
18. Reubi JC, Heitz PU, Landolt AM. 1987 Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses. J Clin Endocrinol Metab. 65:65-73.
19. Moyse E, le Dafniet M, Epelbaum J, et al. 1985 Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas. J Clin Endocrinol Metab. 61:98-103.
20. Hsu DW, Riskind PN, Hedley-Whyte ET. 1989 Vasoactive intestinal peptide in the human pituitary gland and adenomas: an immunocytochemical study. Am J Pathol. 135:329-38.
21. Kourides IA, Weintraub BD, Levko MA, Maloof F. 1974 Alpha and beta subunits of human thyrotropin: purification and development of specific radioimmunoassay. Endocrinology. 94:1411-1421.
22. Gallant AR, Goebel JJ. 1976 Nonlinear regression with autoregressive errors. J Am Stat Assoc. 71:961-967.
23. Ebersold MJ, Quast LM, Laws ER, Scheithauer B, Randall RV. 1986 Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg. 64:713-719.
24. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. 1989 Hypopituitarism following external radiotherapy for pituitary tumors in adults. Q J Med. 70:145-160.
25. Quabbe HJ, Plockinger U. 1989 Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly. J Clin Endocrinol Metab. 68:873-881.
26. Sassolas G, Harris AG, James-Deidier A. 1990 Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. J Clin Endocrinol Metab. 71:391-397.
27. Ho KY, Weissberger AJ, Marbach P, Lazarus L. 1990 Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Ann Intern Med. 112:173-181.
28. Christensen SE, Weeke J, Orskov H, et al. 1987 Continuous subcutaneous pump infusion of somatostatin analogue SMS 201995 versus subcutaneous injection schedule in acromegalic patients. Clin Endocrinol (Oxf). 27:297-306.
29. Reubi JC, Landolt AM. 1989 The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status. J Clin Endocrinol Metab. 68:844-850.
30. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. 1990 Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med. 323:1246-1249.
31. 123I] SDZ 204-090). J Clin Endocrinol Metab. 73:850-856.
32. Lamberts SWJ, Hofland LJ, van Koetsveld PM, et al. 1990 Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab. 71:566-574.
33. Sassolas G, Fossati P, Chanson P, et al. 1989 Experience of a six-month treatment with sandostatin at increasing doses in acromegaly. Horm Res. 31:51-54.
34. Samuels MH, Henry P, Ridgway EC. 1992 Effects of dopamine and somatostatin on pulsatile pituitary glycoprotein secretion. J Clin Endocrinol Metab. 74:217-222.
35. Setyono-Han B, Henkelman MS, Foekens JA, Klijn GM. 1987 Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res. 47:1566-1570.
36. Tornebrandt K, Nobin A, Owman C. 1987 Contractile and dilatory action of neuropeptides on isolated human mesenteric blood vessels. Peptides. 8:251-256.
37. Giannattasio G, Bassetti M. 1990 Human pituitary adenomas. Recent advances in morphological studies. J Endocrinol Invest. 13:435-454.
38. Terzolo M, Orlandi F, Bassetti M, et al. 1991 Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting α-subunit alone and another cosecreting «-subunit and thyrotropin. J Clin Endocrinol Metab. 72:415-421.
39. Gesundheit N, Petrick PA, Nissim M, et al. 1989 Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Ann Intern Med. 111:827-835.
40. Samuels MH, Flenry P, Kleinschmidt-Demasters BK, Lillehei K, Ridgway EC. 1991 Pulsatile glycoprotein hormone secretion in glycoprotein-producing pituitary tumors. J Clin Endocrinol Metab. 73:1281-1288.
41. Gorden P, Comi RJ, Maton PN, Go VL. 1989 Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and nonneoplastic diseases of the gut. Ann Intern Med. 110:35-50.
42. Fanning MM, Monte M, Sutherland LR, Broadhead M, Murphy GF, Harris AG. 1991 Pilot study of sandostatin (octreotide) therapy of refractory HIV-associated diarrhea. Digest Dis Sei. 36:476-480.
43. van Liessum PA, Hopman WP, Pieters GF, et al. 1989 Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly. J Clin Endocrinol Metab. 69:557-562.